相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TOX expression in different subtypes of cutaneous lymphoma
Sohshi Morimura et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2014)
SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis
Minakshi Nihal et al.
CELL CYCLE (2014)
miR-223 Regulates Cell Growth and Targets Proto-Oncogenes in Mycosis Fungoides/Cutaneous T-Cell Lymphoma
Laura Y. McGirt et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Lessons learned from gene expression profiling of cutaneous T-cell lymphoma
B. O. Dulmage et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Impaired Proteasome Function Activates GATA3 in T Cells and Upregulates CTLA-4: Relevance for Sezary Syndrome
Heather M. Gibson et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1BCR-ABL-JAK2 Complex
Min Chen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts
Carolyn S. Lee et al.
BLOOD (2012)
The many roles of TOX in the immune system
Parinaz Aliahmad et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
The role of AHI1 and CDKN1C in cutaneous T-cell lymphoma progression
Ivan V. Litvinov et al.
EXPERIMENTAL DERMATOLOGY (2012)
Chromatin organizer SATB1 is an important determinant of T-cell differentiation
Mithila Burute et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Molecular Markers of Early-Stage Mycosis Fungoides
Yaohua Zhang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Deficiency of SATB1 expression in Sezary cells causes apoptosis resistance by regulating FasL/CD95L transcription
Yang Wang et al.
BLOOD (2011)
The Transcription Factor STAT3 Is Required for T Helper 2 Cell Development
Gretta L. Stritesky et al.
IMMUNITY (2011)
Transcriptional control of T-cell development
Taku Naito et al.
INTERNATIONAL IMMUNOLOGY (2011)
TOX Is Required for Development of the CD4 T Cell Lineage Gene Program
Parinaz Aliahmad et al.
JOURNAL OF IMMUNOLOGY (2011)
p57Kip2 and Cancer: Time for a Critical Appraisal
Adriana Borriello et al.
MOLECULAR CANCER RESEARCH (2011)
Programmed cell death-10 enhances proliferation and protects malignant T cells from apoptosis
Britt Lauenborg et al.
APMIS (2010)
Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma
Maria R. Kamstrup et al.
BLOOD (2010)
Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors
James J. Campbell et al.
BLOOD (2010)
A novel xenograft model of cutaneous T-cell lymphoma
Thorbjorn Krejsgaard et al.
EXPERIMENTAL DERMATOLOGY (2010)
TCRγ-Chain Gene Rearrangement by GeneScan: Incidence and Significance of Clonal Heterogeneity in Sezary Syndrome
Maria T. Fierro et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages
Parinaz Aliahmad et al.
NATURE IMMUNOLOGY (2010)
Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells
Erin Kennah et al.
BLOOD (2009)
Lack of T-Cell Receptor-Induced Signaling Is Crucial for CD95 Ligand Up-regulation and Protects Cutaneous T-Cell Lymphoma Cells from Activation-Induced Cell Death
Claus-Detlev Klemke et al.
CANCER RESEARCH (2009)
Simplified lentivirus vector production in protein-free media using polyethylenimine-mediated transfection
Hitoshi Kuroda et al.
JOURNAL OF VIROLOGICAL METHODS (2009)
Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer
Young-Kook Kim et al.
NUCLEIC ACIDS RESEARCH (2009)
Imprinted CDKN1C Is a Tumor Suppressor in Rhabdoid Tumor and Activated by Restoration of SMARCB1 and Histone Deacetylase Inhibitors
Elizabeth M. Algar et al.
PLOS ONE (2009)
CDKN1C (p57KIP2) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells
Xiaojing Yang et al.
PLOS ONE (2009)
GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation
I-Cheng Ho et al.
NATURE REVIEWS IMMUNOLOGY (2009)
TGF-β:: A master of all T cell trades
Ming O. Li et al.
CELL (2008)
CDK inhibitors: Cell cycle regulators and beyond
Arnaud Besson et al.
DEVELOPMENTAL CELL (2008)
A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS
Xin Mao et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2008)
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma
F. Fornari et al.
ONCOGENE (2008)
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Isabel M. Chu et al.
NATURE REVIEWS CANCER (2008)
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
Elise Olsen et al.
BLOOD (2007)
The cell cycle inhibitor p57Kip2 promotes cell death via the mitochondrial apoptotic pathway
P. Vlachos et al.
CELL DEATH AND DIFFERENTIATION (2007)
Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells
Xiaoyan Jiang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene
Acharawan Topark-Ngarm et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Evidence for an oncogenic role of AHI-1 in Sezary syndrome, a leukemic variant of human cutaneous T-cell lymphomas
A. Ringrose et al.
LEUKEMIA (2006)
Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-cell lymphomas suggesting impaired cell cycle control in disease pathogenesis
Xin Mao et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Immunopathogenesis and therapy of cutaneous T cell lymphoma
EJ Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Early TCR-β and TCR-γ PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma:: diagnostic and prognostic implications
C Assaf et al.
BLOOD (2005)
TOX provides a link between calcineurin activation and CD8 lineage commitment
P Aliahmad et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma
L Kari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3γ1(Ala-Ala)
KC Herold et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Expression of Skp2, a p27Kip1 ubliquitin ligase, in malignant lymphoma:: correlation with p27Kip1 and proliferation index
MS Lim et al.
BLOOD (2002)
A pro-apoptotic effect of the CDK inhibitor p57 Kip2 on staurosporine-induced apoptosis in HeLa cells
MKR Samuelsson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
TOX: an HMG box protein implicated in the regulation of thymocyte selection
B Wilkinson et al.
NATURE IMMUNOLOGY (2002)
分享论文
